Atlas Trials

Livzon Pharmaceutical Group Inc.

28 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Livzon Pharmaceutical Group Inc.

RecordFirmDate
A Study to Evaluate the Efficacy and Safety of LZM012 ( Psoriasis ) (NCT07746479)Livzon Pharmaceutical Group Inc.2025-06-23
A Phase III Clinical Trial for Efficacy and Safety Evaluation of JP-1366 Tablets on Reflux Esophagitis (NCT06850480)Livzon Pharmaceutical Group Inc.2024-12-05
A Study to Evaluate the Efficacy and Safety of LZM012 (NCT06110676)Livzon Pharmaceutical Group Inc.2023-08-21
A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5 (NCT05585567)Livzon Pharmaceutical Group Inc.2022-09-16
Exploratory Clinical Study to Evaluation of the Safety and Immunogenicity of Bivalent Vaccine V-01D-351 (NCT05583357)Livzon Pharmaceutical Group Inc.2022-08-15
Immunogenicity and Safety of Sequential Immunization of Recombinant SARS-CoV-2 Fusion Protein Vaccine (NCT05238649)Livzon Pharmaceutical Group Inc.2021-11-10
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Study (NCT05096832)Livzon Pharmaceutical Group Inc.2021-11-03
Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster Immunization (NCT05125874)Livzon Pharmaceutical Group Inc.2021-09-30
Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Phase III (NCT05096845)Livzon Pharmaceutical Group Inc.2021-08-25
Booster Immunization Study of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) (NCT05050474)Livzon Pharmaceutical Group Inc.2021-08-07
Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity (NCT05239832)Livzon Pharmaceutical Group Inc.2021-08-05
A Multi-center, Double-blinding, Parallel and Positive-controlled Phase III Clinical Trial for Efficacy and Safety Evaluation of Ilaprazole Sodium for Injection on Prevention of Stress Ulcer Bleeding (NCT05841394)Livzon Pharmaceutical Group Inc.2021-07-16
Single-dose Escalation Study of SQ-001 Infusion to Characterize the PK Profiles of Major Sentinel Compounds in Healthy Adult Volunteers in US (NCT04026321)Livzon Pharmaceutical Group Inc.2018-10-03
Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Patients(BCS) With Digestive Tract . (NCT03456609)Livzon Pharmaceutical Group Inc.2018-01-18
Shenqi Fuzheng Injection for the Treatment of Cancer-related Fatigue in Chemo Patients With Digestive Tract . (NCT03455205)Livzon Pharmaceutical Group Inc.2017-12-24

Track Livzon Pharmaceutical Group Inc. automatically

Every clearance here is in the API, with alerts when new ones post.